Ambac Financial Group (OSG) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
7 Jan, 2026Executive summary
Total P&C premium production surged 70% to $318 million for Q1 2025, driven by the Beat Capital acquisition and strong growth in Insurance Distribution and Specialty P&C segments.
Total revenue from continuing operations rose 27% year-over-year to $63 million, mainly due to the Beat acquisition.
Beat Capital contributed over $20 million in revenue, significantly expanding Insurance Distribution.
Net loss attributable to shareholders was $(46) million, compared to net income of $20 million in the prior year, impacted by discontinued operations and higher expenses.
All pre-closing conditions for the sale of the Legacy business were completed; regulatory approval is pending.
Financial highlights
Net loss from continuing operations was $(16) million ($0.58 per share), up from $(4) million in Q1 2024, mainly due to increased amortization and interest expense from the Beat acquisition.
Adjusted EBITDA from continuing operations was a $(1) million loss, compared to a slight profit in Q1 2024.
Consolidated Adjusted EBITDA margin improved to 5.9% from 2.6% year-over-year.
Stockholders' equity stood at $852 million ($18.36 per share) as of March 31, 2025.
Discontinued operations posted a net loss of $30 million ($0.64 per share).
Outlook and guidance
Management targets 2028 adjusted EBITDA of $80–$90 million, up from $18 million in 2024, driven by organic growth, acquisitions, and Everspan contribution.
Market conditions in ESL are stabilizing and expected to turn favorable for growth.
Focus remains on scaling the specialty P&C business and completing the sale of the legacy business.
The AAC sale is expected to close by July 2025, with proceeds to be used for debt repayment and potential reinvestment.
Latest events from Ambac Financial Group
- Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026 - Record premium growth and margin gains offset by $548M net loss from legacy business sale.OSG
Q4 202423 Dec 2025 - Vote on $420M sale of AAC to Oaktree, executive pay, and adjournment; board recommends approval.OSG
Proxy Filing2 Dec 2025 - Shareholders to vote on $420M sale, board-backed, with new capital and governance terms.OSG
Proxy Filing2 Dec 2025 - Transformational year with strategic transactions, strong specialty insurance growth, and enhanced governance.OSG
Proxy Filing2 Dec 2025 - Vote requested on sale of Ambac Assurance Corporation and related executive compensation.OSG
Proxy Filing2 Dec 2025